Literature DB >> 11895511

Cutaneous leishmaniasis in Sanliurfa: epidemiologic and clinical features of the last four years (1997-2000).

Mehmet Salih Gurel1, Mustafa Ulukanligil, Hatice Ozbilge.   

Abstract

BACKGROUND: Sanliurfa is located in south-east Anatolia, the region with the largest focus of anthroponotic cutaneous leishmaniasis (CL) in Turkey. The present study was designed to determine the epidemiological and clinical patterns of cases of CL in the Sanliurfa area over a period of 4 years (1997-2000).
METHODS: 2120 CL cases attending the Harrankapi in this study.
RESULTS: There were 790 cases of CL in 1997, and 778 in 1998. The numbers declined to 277 in 1999 and to 275 in 2000. The majority of patients (70%) were less than 20 years of age, with the highest percentage (27%) occurring in the 5- to 9-year age group. Acute CL and chronic CL were observed in 1926 (90.8%) and 63 (3%) patients, respectively. Leishmaniasis recidivans (LR) was found only in 131 (6.2%) patients. Lesions of CL were seen mainly on the exposed parts of the body such as the face and neck (57.5%), upper limbs (32.2%) and lower limbs (10.2%). Ninety-three percent of the patients were residents of central Sanliurfa from the southern and eastern parts of the city, areas with poor housing and low socio-economic conditions.
CONCLUSION: Although the incidence of CL showed a sharp decline from 1997 to 2000 in Sanliurfa, this does not mean that the disease is on its way to eradication.

Entities:  

Mesh:

Year:  2002        PMID: 11895511     DOI: 10.1046/j.0011-9059.2001.01396.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  21 in total

1.  Hyperkeratotic cutaneous leishmaniasis: A rare presentation.

Authors:  Yavuz Yesilova; Enver Turan; Hacer Altun Sürücü; Ferhat Bozkurt; Fadile Yıldız Zeyrek; Osman Tanrıkulu
Journal:  Balkan Med J       Date:  2013-03       Impact factor: 2.021

2.  Head and neck cutaneous leishmania: clinical characteristics, microscopic features and molecular analysis in a cohort of 168 cases.

Authors:  Gabriel Dunya; Robert Habib; Roger V Moukarbel; Ibrahim Khalifeh
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-15       Impact factor: 2.503

3.  A Comparison of Demographic and Clinical Characteristics of Syrian and Turkish Patients with Cutaneous Leishmaniasis.

Authors:  Enver Turan; Yavuz Yeşilova; Hacer Altun Sürücü; Nurittin Ardic; Nebiye Doni; Mustafa Aksoy; Abdullah Yesilova; Steve Oghumu; Sanjay Varikuti; Abhay R Satoskar
Journal:  Am J Trop Med Hyg       Date:  2015-06-15       Impact factor: 2.345

4.  Pediatric cutaneous leishmaniasis in an endemic region in India.

Authors:  Saurabh Agrawal; Kanika Khandelwal; Ram A Bumb; Steve Oghumu; Poonam Salotra; Abhay R Satoskar
Journal:  Am J Trop Med Hyg       Date:  2014-10-06       Impact factor: 2.345

5.  Molecular identification of Leishmania spp. isolates causes cutaneous leishmaniasis (CL) in Sanliurfa Province, Turkey, where CL is highly endemic.

Authors:  Gulcan Gurses; Mehmet Ozaslan; Fadile Yıldız Zeyrek; Ibrahim H Kılıç; Nebiye Yentür Doni; I Didem Karagöz; Nermin Uluca
Journal:  Folia Microbiol (Praha)       Date:  2017-12-07       Impact factor: 2.099

6.  Case Report: Mucocutaneous Leishmaniasis Masquerading as Idiopathic Midline Granulomatous Disease.

Authors:  Nilesh Tejura; Eunjung Kim; Lisa L Dever; Debra Chew
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

7.  Clinco-epidemiologic study of cutaneous leishmaniasis in Bikaner, Rajasthan, India.

Authors:  Naushin Aara; Kanika Khandelwal; Ram A Bumb; Rajesh D Mehta; Bhikam C Ghiya; Renu Jakhar; Claire Dodd; Poonam Salotra; Abhay R Satoskar
Journal:  Am J Trop Med Hyg       Date:  2013-05-28       Impact factor: 2.345

8.  Anti-leishmanial effects of trinitroglycerin in BALB/C mice infected with Leishmania major via nitric oxide pathway.

Authors:  Hossein Nahrevanian; Mana Najafzadeh; Reza Hajihosseini; Habib Nazem; Mahin Farahmand; Zahra Zamani
Journal:  Korean J Parasitol       Date:  2009-05-27       Impact factor: 1.341

9.  Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report).

Authors:  Mohamad Ali Nilforoushzadeh; Giti Sadeghian; Fariba Jaffary; Hengameh Ziaei; Liela Shirani-Bidabad; Parvin Mahzoni
Journal:  Korean J Parasitol       Date:  2008-09       Impact factor: 1.341

10.  Lupoid cutaneous leishmaniasis: a case report.

Authors:  Aida Khaled; Samia Goucha; Sonia Trabelsi; Rachida Zermani; Bécima Fazaa
Journal:  Dermatol Ther (Heidelb)       Date:  2011-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.